Matches in Nanopublications for { ?s ?p "DDI between Tranylcypromine and Milnacipran - Increased risk of serotonin syndrome. Concomitant therapy should be avoided. A significant washout period, dependent on the half-lives of the agents, should be employed between therapies. [drugbank_resource:DB00752_DB04896]"@en ?g. }
Showing items 1 to 1 of
1
with 100 items per page.
- drugbank_resource:DB00752_DB04896 label "DDI between Tranylcypromine and Milnacipran - Increased risk of serotonin syndrome. Concomitant therapy should be avoided. A significant washout period, dependent on the half-lives of the agents, should be employed between therapies. [drugbank_resource:DB00752_DB04896]" assertion.